CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 246 filers reported holding CATALYST PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.1%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 159,791 | $1,868 | 5.34% |
| Opaleye Management Inc. | 1,205,000 | $14,086,450 | 4.58% |
| GABLES CAPITAL MANAGEMENT INC. | 431,955 | $5,049,554 | 3.51% |
| JW Asset Management, LLC | 563,392 | $6,586,052 | 2.85% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 8,192,000 | $95,764,480 | 2.11% |
| Seaport Global Advisors, LLC | 45,941 | $537,050 | 1.61% |
| Capital Impact Advisors, LLC | 67,067 | $784,013 | 1.31% |
| Ikarian Capital, LLC | 505,862 | $5,913,527 | 0.71% |
| MOODY ALDRICH PARTNERS LLC | 273,512 | $3,197,355 | 0.61% |
| Paradiem, LLC | 166,905 | $1,951,119 | 0.59% |